MDCorp (MDCX) Operating Margin (2024 - 2026)
MDCorp (MDCX) operating margin from Dec 31, 2024 to Mar 31, 2026. The current MDCorp (MDCX) operating margin is -14333.33%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of MDCorp (MDCX)
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -37266.67% | -4669.70% |
| 2023 | 815.52% | N/A |
Comparison MDCorp (MDCX) operating margin with competitors
MDCorp (MDCX) operating margin is -14333.33%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 61.57% | -100.43% |
| GILD | Gilead Sciences Inc | 37.16% | -100.26% |
| NVS | Novartis AG | 31.31% | -100.22% |
| AMGN | AMGEN Inc | 30.94% | -100.22% |
| GSK | GSK Plc | 30.06% | -100.21% |
| AZN | Astrazeneca plc | 27.77% | -100.19% |
| ABBV | Abbvie Inc | 26.60% | -100.19% |
| JNJ | Johnson & Johnson | 26.58% | -100.19% |
| SNY | Sanofi | 20.18% | -100.14% |
| OGN | Organon & Company | 18.22% | -100.13% |
| GRFS | Grifols SA | 14.65% | -100.10% |